|
1 C. Chandrasekhar. Ectopic pregnancy: A pictorial review[J].Clin Imag, 2008,32:468-473.
|
|
2 Carr RJ, Evans P. Ectopic pregnancy[J]. Prim Care, 2000,27:169-183.
|
|
3 Barnhart KT, Gosman G, Ashby R, et al. The medical management of ectopic pregnancy: A meta-analysis comparing " single dose" and " multidose" regimens[J]. Obstet Gynecol, 2003,101:778-784.
|
|
4 Alleyassin A, Khademi A, Aghahosseini M, et al. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: A prospective, randomized clinical trial[J]. Fertil Steril, 2006,85:1661-1666.
|
|
5 Lipscomb GH, Givens VA, Meyer NL,et al. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy[J]. Am J Obstet Gynecol,2005,192:1847-1848.
|
|
6 Guven ES, Dilbaz S. Comparison of the effect of single-dose and multiple-dose methotrexate therapy on tubal patency[J]. Fertil Steril,2007,88(5):1288-1292.
|
|
7 Menon S, Colins J, Barnhart KT. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: A systematic review[J]. Fertil Steril, 2007,87:481-484.
|
|
8 Mol F, Mol BW, Ankum F, et al. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: A systematic review and meta-analysis[J]. Hum Reprod Update,2008,14(4): 309-319.
|
|
9 Hajenius PJ, Mol F, Mol BW, et al. Interventions for tubal ectopic pregnancy[J]. Cochrane Database Syst Rev, 200, (2): CD000324.
|
|
10 Da Costa Soares R, Elito J Jr, Camano L. Increment in beta-hCG in the 48-h period prior to treatment: A new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate [J]. Arch Gynecol Obstet, 2008, 278(4): 319-324.
|
|
11 Lipscomb GH, Givens VA, Meyer NL, et al. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy[J]. Fertil Steril, 2004, 81: 1221-1224.
|
|
12 Bixby S, Tello R, Kuligowska E. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy[J]. J Ultrasound Med, 2005, 24(5): 591-598.
|
|
13 Elito J Jr, Reichmann AP, Uchiyama MN, et al. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate[J]. Int J Gynaecol Obstet, 1999, 67(2): 75-79.
|
|
14 Kahyaoglu S,Turgay I,Gocmen M, et al. A new predictive scoring system including shock index for unruptured tubal pregnancy patients[J].Eur J Obstet Gynecol Repred Biol, 2006, 126(1): 99-109.
|
|
15 Yang WL, Jia PY, Zhang YP, et al. Clinical scoring system for the treatment of ectopic pregnancy[J]. Matern Child Health Care China, 2008, 23(31): 4396-4397. [杨文兰,贾平英,张运平,等. 异位妊娠治疗临床评分[J]. 中国妇幼保健,2008, 23(31): 4396-4397.]
|
|
16 Song HD, Chen SL, He JX, et al. Combined use of methotrexate and mifepristone for ectopic pregnancy management: A meta-analysis [J]. J First Military Med Univ, 2006, 26(12): 1815-1817. [宋华东,陈士岭,何锦霞,等. 氨甲喋呤联合米非司酮治疗异位妊娠的Meta分析[J]. 南方医科大学学报,2006, 26(12): 1815-1817.]
|
|
17 Ocal P, Erkan S. Transvaginal ultrasound-guided aspiration and instillation of hyperosmolar glucose for treatment of unruptured tubal heterotopic pregnancy[J]. Arch Gynecol Obstet, 2007, 276(3): 386-389.
|
|
18 Smorgick N, Vaknin Z, Pansky M, et al. Combined local and systemic methotrexate treatment of viable ectopic pregnancy: Outcomes of 31 cases [J]. J Clin Ultrasound, 2008, 36(9): 1109-1112.
|
|
19 Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar [J]. Ultrasound Obstet Gynecol, 2000, 16(16): 592-593.
|
|
20 Seow KM, Huan LW, Lin YH, et al. Caesarean scar pregnancy: Issues in management [J]. Ultrasound Obstet Gynecol, 2004, 23(1): 247-253.
|
|
21 Maymon R, Halperin R, Mendlovic S, et al. Ectopic pregnancies in a caesarean scar: Review of the medical approach to an iatrogenic complication[J]. Hum Reprod Update, 2004, 10: 515-523.
|
|
22 Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: Etiology, diagnosis and management[J]. Obstet Gynecol, 2006, 107: 1373-1377.
|
|
23 Hwu YM, Hsu CY, Yang HY. Conservative treatment of caesarean scar pregnancy with transvaginal needle aspiration of the embryo [J]. BJOG, 2005, 112: 841-842.
|
|
24 Muraji M, Mabuchi S, Hisamoto K. Cesarean scar pregnancies successfully treated with methotrexate [J]. Acta Obstet Gynecol Scand, 2009, 88(6): 678-682.
|